The Egyptian Medicines Authority received today, Sunday, November 24, headed by Dr. Ali Al-Ghamrawi, a high-level delegation from the World Health Organization, headed by Dr. Heiti Silo, leader of the World Health Organization team. The delegation included 3 levels of representation in the World Health Organization, which are the organization’s headquarters team in Geneva, the regional team for the Eastern Mediterranean, and the team representing the World Health Organization in the Republic of Arab Egypt.
The visit, which extends over two consecutive days, comes within the sustainable cooperation program between the two sides with the aim of strengthening the national regulatory system. The delegation will review the recent developments and updates that the pharmaceutical sector in Egypt has witnessed, and discuss the development plan for regulatory procedures for medical preparations. The visit aims to make the most of the strengths of the Egyptian Pharmaceutical Authority’s regulatory system, thus enhancing its regional and international standing.
< p>
In his opening speech, Dr. Ali Al-Ghamrawi stressed the Authority’s keenness to continuously advance and develop the pharmaceutical sector, in line with Egypt’s vision. 2030, the national policies supporting this field, and the directives of the political leadership regarding the priority of the pharmaceutical sector and the localization of medical preparations in Egypt, He pointed to the continuous efforts made by the authority to obtain high-level international accreditations, most notably the accreditation of the World Health Organization in the field of medical preparations, stressing the importance of these steps in enhancing the competitiveness of Egyptian pharmaceutical products and medical supplies at the regional and international levels, and opening new export markets. In front of Egyptian medical preparations and supplies, and giving the Egyptian product a global reputation and the confidence of major international institutions working in the health and medicine sector.
He also expressed the Authority’s thanks for supporting the Health Organization. Permanent globalization, which has yielded tangible and sustainable results in tightening control over the circulation of medical preparations in the pharmaceutical market in Egypt, and the reputation of Egyptian medicine.
For his part, Dr. Heiti Silo praised the pivotal role For Egypt in formulating regional health and pharmaceutical policies, stressing that the developments witnessed by the pharmaceutical sector during the current period in Egypt are large and successful, and reflect positively on the health of Egyptian citizens, and their effects extend to all parts of the African continent. And the interlocutor Arab and regional countries. He also praised the continuous efforts made by the Egyptian Medicines Authority to align its practices with the best international standards, in line with the Global Assessment Tool for Drug Regulatory Bodies (GBT) of the World Health Organization.
p>
The visit confirms the Egyptian Medicines Authority’s keenness to strengthen its partnerships and its position at the international level, and its effective role in supporting the pharmaceutical sector locally, regionally and internationally, in a way that contributes to achieving development goals. Sustainable and ensuring the health and safety of all.
This comes within the framework of the Authority’s keenness to benefit from global expertise and the experiences of relevant regulatory institutions, keep pace with global developments, and obtain international accreditations in the field of Vaccines and medical preparations.
